Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Ehrlich

Showing results (231-240 of 278) with videos related to

Pageof 28
Sort By:
Nucleic Acids Research|June 11, 1994
Direct detection of nucleic acid hybridization on the surface of a charge coupled deviceJ B Lamture, K L Beattie, B E Burke, et al.
The Journal of Infectious Diseases|May 20, 2011
A tick-borne encephalitis virus vaccine based on the European prototype strain induces broadly reactive cross-neutralizing antibodies in humansKlaus K Orlinger, Yvonne Hofmeister, Richard Fritz, et al.
Obstetrics and Gynecology|July 29, 2010
Complex hyperplasia with and without atypia: clinical outcomes and implications of progestin therapySusan D Reed, Katherine M Newton, Rochelle L Garcia, et al.
BMC Neurology|April 2, 2024
A randomized feasibility trial of medium chain triglyceride-supplemented ketogenic diet in people with Parkinson's diseaseAlexander H Choi, Melanie Delgado, Kong Y Chen, et al.
Virology Journal|April 18, 2014
Hyperimmune intravenous immunoglobulin containing high titers of pandemic H1N1 hemagglutinin and neuraminidase antibodies provides dose-dependent protection against lethal virus challenge in SCID miceChristine Hohenadl, Walter Wodal, Astrid Kerschbaum, et al.
Antibiotics & Chemotherapy (Northfield, Ill.)|February 19, 2014
Elaiomycin, a new tuberculostatic antibiotic; biologic studiesJ EHRLICH, L E ANDERSON, G L COFFEY, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 25, 2023
Long-term safety of MRI-guided administration of AAV2-GDNF and gadoteridol in the putamen of individuals with Parkinson's diseaseMatthew T Rocco, Asad S Akhter, Debra J Ehrlich, et al.
Transfusion|October 11, 2011
Preparation of commercial quantities of a hyperimmune human intravenous immunoglobulin preparation against an emerging infectious disease: the example of pandemic H1N1 influenzaThomas R Kreil, John K Mc Vey, Laura Shau-Ping Lei, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 12, 2022
Long-term safety of MRI-guided administration of AAV2-GDNF and gadoteridol in the putamen of individuals with Parkinson's diseaseMatthew T Rocco, Asad S Akhter, Debra J Ehrlich, et al.
Journal of Paediatrics and Child Health|April 1, 1996
Late-onset infections of infants in neonatal unitsD Isaacs, C Barfield, T Clothier, et al.
Pageof 28

Showing results (231-240 of 278) with videos related to

Sort By:
Pageof 28
Nucleic Acids Research|June 11, 1994
Direct detection of nucleic acid hybridization on the surface of a charge coupled deviceJ B Lamture, K L Beattie, B E Burke, et al.
The Journal of Infectious Diseases|May 20, 2011
A tick-borne encephalitis virus vaccine based on the European prototype strain induces broadly reactive cross-neutralizing antibodies in humansKlaus K Orlinger, Yvonne Hofmeister, Richard Fritz, et al.
Obstetrics and Gynecology|July 29, 2010
Complex hyperplasia with and without atypia: clinical outcomes and implications of progestin therapySusan D Reed, Katherine M Newton, Rochelle L Garcia, et al.
BMC Neurology|April 2, 2024
A randomized feasibility trial of medium chain triglyceride-supplemented ketogenic diet in people with Parkinson's diseaseAlexander H Choi, Melanie Delgado, Kong Y Chen, et al.
Virology Journal|April 18, 2014
Hyperimmune intravenous immunoglobulin containing high titers of pandemic H1N1 hemagglutinin and neuraminidase antibodies provides dose-dependent protection against lethal virus challenge in SCID miceChristine Hohenadl, Walter Wodal, Astrid Kerschbaum, et al.
Antibiotics & Chemotherapy (Northfield, Ill.)|February 19, 2014
Elaiomycin, a new tuberculostatic antibiotic; biologic studiesJ EHRLICH, L E ANDERSON, G L COFFEY, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 25, 2023
Long-term safety of MRI-guided administration of AAV2-GDNF and gadoteridol in the putamen of individuals with Parkinson's diseaseMatthew T Rocco, Asad S Akhter, Debra J Ehrlich, et al.
Transfusion|October 11, 2011
Preparation of commercial quantities of a hyperimmune human intravenous immunoglobulin preparation against an emerging infectious disease: the example of pandemic H1N1 influenzaThomas R Kreil, John K Mc Vey, Laura Shau-Ping Lei, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 12, 2022
Long-term safety of MRI-guided administration of AAV2-GDNF and gadoteridol in the putamen of individuals with Parkinson's diseaseMatthew T Rocco, Asad S Akhter, Debra J Ehrlich, et al.
Journal of Paediatrics and Child Health|April 1, 1996
Late-onset infections of infants in neonatal unitsD Isaacs, C Barfield, T Clothier, et al.
Pageof 28